<code id='AF8C8B5E29'></code><style id='AF8C8B5E29'></style>
    • <acronym id='AF8C8B5E29'></acronym>
      <center id='AF8C8B5E29'><center id='AF8C8B5E29'><tfoot id='AF8C8B5E29'></tfoot></center><abbr id='AF8C8B5E29'><dir id='AF8C8B5E29'><tfoot id='AF8C8B5E29'></tfoot><noframes id='AF8C8B5E29'>

    • <optgroup id='AF8C8B5E29'><strike id='AF8C8B5E29'><sup id='AF8C8B5E29'></sup></strike><code id='AF8C8B5E29'></code></optgroup>
        1. <b id='AF8C8B5E29'><label id='AF8C8B5E29'><select id='AF8C8B5E29'><dt id='AF8C8B5E29'><span id='AF8C8B5E29'></span></dt></select></label></b><u id='AF8C8B5E29'></u>
          <i id='AF8C8B5E29'><strike id='AF8C8B5E29'><tt id='AF8C8B5E29'><pre id='AF8C8B5E29'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:49
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+
          What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

          6:14PomKlementieffasMantis,Groot(voicedbyVinDiesel),ChrisPrattasPeterQuill/Star-Lord,DaveBautistaasD

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

          6:14PomKlementieffasMantis,Groot(voicedbyVinDiesel),ChrisPrattasPeterQuill/Star-Lord,DaveBautistaasD